Efficacy and Safety of Two Hair Supplements in Men With Androgenic Alopecia

The goal of this clinical trial is to evaluate the efficacy and safety of two differentformulations of a food supplement on hair health in healthy Caucasian male subjects aged35 to 65 years with mild to moderate androgenetic alopecia. The main questions it aims toanswer are: ‐ Whether the two formulations improve hair growth and reduce hair loss after 42 and84 days, as assessed by phototricogram parameters. ‐ Whether the two formulations improve hair brightness, and colour lightness after 42and 84 days, as assessed by spectrophotometer/colorimeter.Researchers will compare two active supplement groups and a placebo group to determinewhether the active products improve objective hair parameters and perceived hair quality.Participants will: ‐ be randomized to one of three groups : Active 1, Active 2 or Placebo; ‐ take one capsule daily at breakfast for 84 days; ‐ attend clinical visits at baseline, Day 42, and Day 84; ‐ undergo hair assessments including pull test, phototrichogram, andspectrophotometer/colorimeter measurements; ‐ complete a self‐assessment questionnaire at follow‐up visits; ‐ be monitored for safety and tolerability throughout the study.